PSMB9 and cancer: Mishto et al. [27] reported that i-proteasome activity was significantly higher in individuals with the PSMB9 rs17587 G/G genotype than in those with the heterozygous G/A genotype, suggesting that heterozygosity is not associated with cancer risk.